DESPITE THE PANDEMIC, investors continue to support emerging in vitro diagnostics (IVD) companies. This is particularly true of start-up companies that want to develop clinical lab testing systems that can be used at the point of care, that require small amounts of blood, and that deliver accurate results in just minutes. That would describe the […]
- IVD Update
Truvian Sciences Raises $105M for Near-Patient Lab Test System
San Diego company hopes to obtain FDA clearance for its multi-analyte analyzer that uses drops of blood
- By Robert Michel
- > From the Volume XXVIII, No. 4 - March 22, 2021 Issue
